Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Human Genomics|December 30, 2016
The status of Her2 amplification and Kras mutations in mucinous ovarian carcinomaKuang-Leei Chang, Ming-Yung Lee, Wan-Ru Chao, et al.
Taiwanese Journal of Obstetrics & Gynecology|November 19, 2021
High frequency of BRAF mutations in primary mucinous ovarian carcinoma of Taiwanese patientsWan-Ru Chao, Yi-Ju Lee, Ming-Yung Lee, et al.
The American Journal of Surgical Pathology|August 19, 2014
Assessing the HER2 status in mucinous epithelial ovarian cancer on the basis of the 2013 ASCO/CAP guideline updateWan-Ru Chao, Ming-Yung Lee, Wea-Lung Lin, et al.
Taiwanese Journal of Obstetrics & Gynecology|September 11, 2025
HER2 mutation profiling in mucinous ovarian carcinoma: Inferences for Enhertu (trastuzumab deruxtecan) as a potential therapeutic approachHuang-Pin Shen, Ming-Yung Lee, Wan-Ru Chao, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 30, 2024
HER2 mutations in advanced cervical neuroendocrine carcinoma: implications for trastuzumab deruxtecan therapyWan-Ru Chao, Ming-Yung Lee, Gwo-Tarng Sheu, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|April 6, 2017
Association of Fibroblast Growth Factor Receptor 4 Genetic Polymorphisms With the Development of Uterine Cervical Cancer and Patient PrognosisTze-Ho Chen, Shun-Fa Yang, Yu-Fan Liu, et al.
Pageof 5